Since 2021, when lung cancer screening guidelines began to include younger people and those with a lower smoking history, the number of screenings climbed, but significant gaps remain, especially ...

Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a Phase 1 study of ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

A linear accelerator is a radiation treatment machine where we use high energy x-rays and electrons to treat both cancer and ...

UPMC Horizon-Shenango Valley has added a new linear accelerator to its radiation treatment options at its UPMC Hillman Cancer Center.

Mercer and Lawrence County residents now have access to the most sophisticated radiation oncology treatment at UPMC Hillman Cancer ...

We enrolled USA Veterans with stage I–IIIA lung cancer who completed the primary mode of curative intent therapy (ie, surgical resection, definitive radiation, or concurrent chemoradiation) in the ...

“These can occur from any of the sources, including medical treatments like radiation treatment for cancer, nuclear accidents, industrial radiation exposure, and prolonged sun exposure,” said Dr ...

When you have unresectable lung cancer-- which means surgery isn't an option -- treatments like chemotherapy, radiation, immunotherapy, and targeted therapy can slow the disease. Each of these may ...

If symptoms are present, they are often similar to symptoms of primary lung cancer, like: The results of these imaging studies may provide enough evidence of metastases, although a biopsy may be ...

The primary outcome was completing treatment. For breast cancer, that included surgery, radiation and chemotherapy. For lung cancer, it was either surgery or stereotactic body radiotherapy ...

Ongoing developments of novel therapies and advancing existing therapies such as immunotherapies, target therapies, radiation therapy, and photodynamic therapies are trending in the global lung cancer ...